| 14:00 | P4290 | Characterization of human valvular interstitial cells isolated from normal and fibrocalcified aortic valves. | Anais ARBESU Y MIAR (Lille Cedex, FR) |
|
| 14:00 | P4291 | Histological and molecular fingerprints of low-gradient aortic stenosis | Tudor POERNER (Jena, DE) |
|
| 14:00 | P4292 | Angiogenic and angiostatic factors in patients with coronary artery disease and mitral annulus and/or aortic valve calcification | Michael SPONDER (Vienna, AT) |
|
| 14:00 | P4293 | Circulating bone turnover markers in patients with severe aortic stenosis | Ekaterina ZHIDULEVA (St.Petersburg, RU) |
|
| 14:00 | P4294 | Leptin is expressed in human calcific aortic valves and promotes osteoblastic differentiation of aortic valvular interstitial cells: a new regulatory mechanism of valvular calcification | Mickael ROSA (Lille Cedex, FR) |
|
| 14:00 | P4295 | Extracellular pyrophosphate accumulation is reduced in aortic interstitial valve cells acquiring a calcifying profile: implications for aortic valve calcification | Marcello RATTAZZI (Padova, IT) |
|
| 14:00 | P4296 | Angiotensinogen plasma levels and progression of LV hypertrophy in patients with aortic stenosis - the PROGRESSA study | Philippe PIBAROT (Quebec, CA) |
|
| 14:00 | P4297 | Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolemia | Sven BOS (Rotterdam, NL) |
|
| 14:00 | P4298 | Difference in eNOS expression and oxidative stress between fibrotic and calcified aortic stenosis | Munenori TAKATA (Tokyo Metropolice, JP) |
|
| 14:00 | P4299 | Notch-1 gene mutations and biomarkers of calcification in patients with aortic stenosis | Olga IRTYUGA (St-Petersburg, RU) |
|
| 14:00 | P4300 | Plasma YKL-40 levels are elevated and predict mortality in patients with aortic stenosis | Fizza Kanwal ARAIN (Oslo, NO) |
|
| 14:00 | | Do microRNAs expression label left ventricular outflow tract diseases in bicuspid aortic valve patients? | |
|